NCT00002128已完成1 期
Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 15
- 试验地点
- 2
研究概览
简要总结
To study the safety, tolerance, and pharmacokinetics of a single dose of bis-POM PMEA (adefovir dipivoxil) when administered by the oral route in patients with HIV infection.
详细描述
Five patients are entered at each of three dose levels of bis-POM PMEA administered orally in a single dose.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected ChildrenHIV InfectionsNCT00000843National Institute of Allergy and Infectious Diseases (NIAID)24
已完成
1 期
A Phase I/II Study of the Safety, Tolerance, and Pharmacokinetics of 9-(2-Phosphonylmethoxyethyl)Adenine ( PMEA; Adefovir ) in Patients With Advanced HIV Disease.HIV InfectionsNCT00002115Gilead Sciences20
已完成
1 期
Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic PatientsDyslipidemiasFamilial HypercholesterolemiaHypertriglyceridemiaNCT03747224Arrowhead Pharmaceuticals93
已完成
1 期
2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Healthy SubjectsHealthyNCT01733875Celgene65
已完成
1 期
Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid TumorsSolid TumorsNCT02610361BeiGene131